# Chang‐Min Choi
**Type:** Researchers
**Canonical URL:** https://scholariq.org/researchers/chang-min-choi/
## Facts
| Field | Value |
| --- | --- |
| Citations | 11,089 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 46 |
| i10-index | 176 |
| Last Known Institution | Ulsan College |
| OpenAlex ID | https://openalex.org/A5041035234 |
| ORCID iD | 0000-0002-2881-4669 |
| Works | 507 |
## Researcher papers
- [Comprehensive genomic profiles of small cell lung cancer](https://scholariq.org/papers/comprehensive-genomic-profiles-of-small-cell-lung-cancer/)
- [Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer](https://scholariq.org/papers/activation-of-the-axl-kinase-causes-resistance-to-egfr-targeted-therapy-in-lung/)
- [Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer](https://scholariq.org/papers/exosomal-pd-l1-promotes-tumor-growth-through-immune-escape-in-non-small-cell/)
- [Evaluation of Pulmonary Nodules](https://scholariq.org/papers/evaluation-of-pulmonary-nodules/)
- [Clinicopathologic implication of ALK rearrangement in surgically resected lung cancer](https://scholariq.org/papers/clinicopathologic-implication-of-alk-rearrangement-in-surgically-resected-lung/)
- [MET and AXL Inhibitor NPS-1034 Exerts Efficacy against Lung Cancer Cells Resistant to EGFR Kinase Inhibitors Because of MET or AXL Activation](https://scholariq.org/papers/met-and-axl-inhibitor-nps-1034-exerts-efficacy-against-lung-cancer-cells/)
- [Exploratory Clinical Trial of (4 S )-4-(3-\[18F\]fluoropropyl)- l -glutamate for Imaging xC− Transporter Using Positron Emission Tomography in Patients with Non–Small Cell Lung or Breast Cancer](https://scholariq.org/papers/exploratory-clinical-trial-of-4-i-s-i-4-3-18f-fluoropropyl-scp-l-scp-glutamate/)
- [Outcomes in patients with Mycobacterium abscessus pulmonary disease treated with long-term injectable drugs](https://scholariq.org/papers/outcomes-in-patients-with-mycobacterium-abscessus-pulmonary-disease-treated-with/)
- [Epithelial‐mesenchymal transition leads to crizotinib resistance in H2228 lung cancer cells with EML4‐ALK translocation](https://scholariq.org/papers/epithelial-mesenchymal-transition-leads-to-crizotinib-resistance-in-h2228-lung/)
- [Detection of EGFR mutations in circulating free DNA by PNA-mediated PCR clamping](https://scholariq.org/papers/detection-of-egfr-mutations-in-circulating-free-dna-by-pna-mediated-pcr-clamping/)
- [Efficacy, safety, and resistance profile of osimertinib in T790M mutation-positive non-small cell lung cancer in real-world practice](https://scholariq.org/papers/efficacy-safety-and-resistance-profile-of-osimertinib-in-t790m-mutation-positive/)
## Researcher topics
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
## Researcher university
- [Ulsan College](https://scholariq.org/institutions/ulsan-college/)
---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.